GB9926251D0 - Pharmaceutical formulation - Google Patents

Pharmaceutical formulation

Info

Publication number
GB9926251D0
GB9926251D0 GBGB9926251.1A GB9926251A GB9926251D0 GB 9926251 D0 GB9926251 D0 GB 9926251D0 GB 9926251 A GB9926251 A GB 9926251A GB 9926251 D0 GB9926251 D0 GB 9926251D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical formulation
formulation
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9926251.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott GmbH and Co KG
Original Assignee
Knoll GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll GmbH filed Critical Knoll GmbH
Priority to GBGB9926251.1A priority Critical patent/GB9926251D0/en
Publication of GB9926251D0 publication Critical patent/GB9926251D0/en
Priority to JP2001536140A priority patent/JP2003519622A/en
Priority to CA002390128A priority patent/CA2390128A1/en
Priority to PCT/EP2000/010582 priority patent/WO2001034140A1/en
Priority to AU13885/01A priority patent/AU1388501A/en
Priority to EP00975935A priority patent/EP1274412A1/en
Priority to ARP000105818A priority patent/AR029406A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
GBGB9926251.1A 1999-11-06 1999-11-06 Pharmaceutical formulation Ceased GB9926251D0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GBGB9926251.1A GB9926251D0 (en) 1999-11-06 1999-11-06 Pharmaceutical formulation
JP2001536140A JP2003519622A (en) 1999-11-06 2000-10-27 Pharmaceutical preparations
CA002390128A CA2390128A1 (en) 1999-11-06 2000-10-27 Pharmaceutical formulation
PCT/EP2000/010582 WO2001034140A1 (en) 1999-11-06 2000-10-27 Pharmaceutical formulation
AU13885/01A AU1388501A (en) 1999-11-06 2000-10-27 Pharmaceutical formulation
EP00975935A EP1274412A1 (en) 1999-11-06 2000-10-27 Pharmaceutical formulation
ARP000105818A AR029406A1 (en) 1999-11-06 2000-11-03 PHARMACEUTICAL COMPOSITION THAT INCLUDES A COMPOUND OF (4-CHLOROPHENYL, CYCLLOBUTIL) AMINA, SUCH COMPOUND AND ITS USE TO PREPARE THE SAME

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9926251.1A GB9926251D0 (en) 1999-11-06 1999-11-06 Pharmaceutical formulation

Publications (1)

Publication Number Publication Date
GB9926251D0 true GB9926251D0 (en) 2000-01-12

Family

ID=10864032

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9926251.1A Ceased GB9926251D0 (en) 1999-11-06 1999-11-06 Pharmaceutical formulation

Country Status (7)

Country Link
EP (1) EP1274412A1 (en)
JP (1) JP2003519622A (en)
AR (1) AR029406A1 (en)
AU (1) AU1388501A (en)
CA (1) CA2390128A1 (en)
GB (1) GB9926251D0 (en)
WO (1) WO2001034140A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1622600A1 (en) * 2003-04-28 2006-02-08 Cipla Ltd. Pharmaceutical formulation comprising anti-obesity agent and acidulant
KR100781882B1 (en) * 2005-07-12 2007-12-05 주식회사유한양행 A pharmaceutical composition containing sibutramine
KR100857724B1 (en) 2006-06-30 2008-09-10 한올제약주식회사 The solid dispersion of an oral medication for improved the solubility and dissolution rate of poorly water soluble sibutramine
KR100886542B1 (en) 2007-02-16 2009-03-02 주식회사 드림파마 A composition for solubilizing sibutramine and a method for preparing the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE61928B1 (en) * 1988-11-29 1994-11-30 Boots Co Plc Treatment of obesity
US5459164A (en) * 1994-02-03 1995-10-17 Boots Pharmaceuticals, Inc. Medical treatment

Also Published As

Publication number Publication date
AU1388501A (en) 2001-06-06
CA2390128A1 (en) 2001-05-17
AR029406A1 (en) 2003-06-25
EP1274412A1 (en) 2003-01-15
WO2001034140A1 (en) 2001-05-17
JP2003519622A (en) 2003-06-24

Similar Documents

Publication Publication Date Title
PL351526A1 (en) Pharmaceutical formulation comprising amoxycillin
AU4328800A (en) Pharmaceutical formulation
HK1045102A1 (en) Pharmaceutical formulations
GB9818927D0 (en) Pharmaceutical formulation
IL148543A0 (en) Pharmaceutical carrier formulation
GB9909154D0 (en) Pharmaceutical formulation
GB9822333D0 (en) Pharmaceutical formulation
GB9926251D0 (en) Pharmaceutical formulation
GB9906126D0 (en) Pharmaceutical formulations
GB9930578D0 (en) Pharmaceutical formulations
GB9817470D0 (en) Pharmaceutical formulation
GB9802617D0 (en) Pharmaceutical formulation
GB9930700D0 (en) Pharmaceutical formulation
GB9910636D0 (en) Pharmaceutical formulation
GB9917774D0 (en) Pharmaceutical formulation
GB9917775D0 (en) Pharmaceutical formulation
GB9917777D0 (en) Pharmaceutical formulation
GB9930878D0 (en) Pharmaceutical formulation
GB9927685D0 (en) Pharmaceutical formulation
GB9910633D0 (en) Pharmaceutical formulation
GB9919840D0 (en) Pharmaceutical formulation
GB9921396D0 (en) Pharmaceutical formulation
GB9917772D0 (en) Pharmaceutical formulation
GB9922187D0 (en) Pharmaceutical formulation
EP1414417A4 (en) Pharmaceutical formulation

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)